← Eichor
Study identifier: NCT07710664 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region

Condition: Persistent HPV16 Infection  ·  Sponsor: Newish Biotech (Wuxi) Co., Ltd.

PhasePhase 1
Planned participants10
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

This is an open-label, single-center, investigator-initiated exploratory trial evaluating NWRD09 in 10 participants with persistent HPV16 infection in the anal region.

This description comes directly from the study's public registry record.

Talk to the study team

Dr. Chen Zeyang, MD  ·  +86-13051555186  ·  chenzeyang_pku@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University First HospitalBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07710664